Theravance Biopharma TBPH Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's total current assets?
- Theravance Biopharma (TBPH) reported total current assets of $417.63M in Q1 2026.
- How has Theravance Biopharma's total current assets changed year-over-year?
- Theravance Biopharma's total current assets increased by 177.9% year-over-year, from $150.26M to $417.63M.
- What is the long-term trend for Theravance Biopharma's total current assets?
- Over 5 years (2020 to 2025), Theravance Biopharma's total current assets has grown at a 1.2% compound annual growth rate (CAGR), from $393.34M to $418.46M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.